A detailed history of Cubist Systematic Strategies, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 6,800 shares of ABT stock, worth $807,636. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,800
Previous 136,100 95.0%
Holding current value
$807,636
Previous $14.1 Million 94.52%
% of portfolio
0.0%
Previous 0.1%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $16.4 Million - $18.1 Million
149,970 New
149,970 $17 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $22.4 Million - $26.9 Million
234,816 New
234,816 $22.7 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $46.5 Million - $54.8 Million
480,243 Added 4680.27%
490,504 $49.7 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $18.6 Million - $21.8 Million
-195,602 Reduced 95.02%
10,261 $1.13 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $23.6 Million - $27.3 Million
-244,018 Reduced 54.24%
205,863 $19.9 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $3.58 Million - $4.33 Million
35,103 Added 8.46%
449,881 $48.9 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $31.8 Million - $38.8 Million
278,953 Added 205.38%
414,778 $49.1 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $2.36 Million - $2.89 Million
20,398 Added 17.67%
135,825 $19.1 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $3.89 Million - $4.31 Million
33,377 Added 40.68%
115,427 $13.6 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $10.9 Million - $12.8 Million
-102,882 Reduced 55.63%
82,050 $9.51 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $13.1 Million - $15.5 Million
120,817 Added 188.44%
184,932 $22.2 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $509,670 - $555,394
-4,854 Reduced 7.04%
64,115 $7.02 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $2.23 Million - $2.7 Million
-24,291 Reduced 26.05%
68,969 $7.51 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $675,423 - $864,458
8,821 Added 10.45%
93,260 $8.53 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $5.1 Million - $7.46 Million
81,212 Added 2516.64%
84,439 $6.66 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $755,972 - $841,574
-9,629 Reduced 74.9%
3,227 $280,000
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $548,819 - $595,090
6,706 Added 109.04%
12,856 $1.08 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $306,168 - $357,085
4,201 Added 215.55%
6,150 $517,000
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $129,062 - $156,036
1,949 New
1,949 $156,000
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $455,707 - $516,250
-6,951 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $2.08 Million - $2.51 Million
-34,272 Reduced 83.14%
6,951 $510,000
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $1.94 Million - $2.14 Million
-33,723 Reduced 45.0%
41,223 $2.51 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $1.31 Million - $1.49 Million
23,367 Added 45.3%
74,946 $4.49 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $1.76 Million - $1.89 Million
32,814 Added 174.87%
51,579 $2.94 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $901,845 - $1.01 Million
18,765
18,765 $1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.